ARTICLE | Distillery Therapeutics
Hepatic; renal
April 12, 2017 3:45 PM UTC
Cell culture and mouse studies suggest inhibiting FOXO4 could help treat drug-induced liver toxicity and age-related renal dysfunction. In a mouse model of doxorubicin-induced hepatotoxicity, a cell-p...
BCIQ Company Profiles
BCIQ Target Profiles